Author:
Pham Thao,Claudepierre Pascal,Constantin Arnaud,de Bandt Michel,Fautrel Bruno,Gossec Laure,Gottenberg Jacques-Eric,Goupille Philippe,Guillaume Séverine,Hachulla Eric,Masson Charles,Morel Jacques,Puéchal Xavier,Saraux Alain,Schaeverbeke Thierry,Wendling Daniel,Bruckert Eric,Pol Stanislas,Mariette Xavier,Sibilia Jean
Reference136 articles.
1. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with anlylosing spondylitis or psoriatic arthritis : 2007 update;Pham;Joint Bone Spine,2007
2. Rituximab (Mabthera®) therapy and safety management;Pham;Joint Bone Spine,2008
3. Abatacept therapy and safety management;Pham;Joint Bone Spine,2009
4. Summary of Product Characteristics for tocilizumab. EMA 2009. http://www.emea.europa.eu/
5. Prise en charge thérapeutique du patient dyslipidémique. AFSSAPS 2005. http://www.afssaps.fr/Infos-de-securite/Recommandations-de-bonne-pratique/Prise-encharge-du-patient-dyslipidemique/
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献